GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PharmaEngine 4162.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

52.20

-1.32%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About PharmaEngine

Its shares trade on Taipei Exchange under the ticker 4162.TWO. It has been listed since 1 September 2011. In the fiscal year to 31 December 2025, it reported revenue of TWD 911.4m and net income of TWD 387.6m. At that date it held total assets of TWD 5.15bn and shareholders' equity of TWD 4.93bn.

PharmaEngine, Inc. engages in the research, development and manufacture of biopharmaceutical products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2011-09-01. The firm is developing three new anti-cancer drugs under the brand of ONIVYDE, which are nal-IRI, MM-398 and PEP02. The firm distributes its products mainly to overseas markets,

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
1 Sept 2011
Employees
16,000

Leadership

Pay as last reported

  • Mr. Jan-Yau HsuChairman of the Board, since 2022TWD 4.5m
  • Mr. Hong-Ren WangGeneral Manager
  • Mr. Chi-Hsing ChangDeputy General Manager-Corporate Development, Corporate Governance Officer
  • Ms. Peggy TsaoHead of Finance & Accounting
  • Mr. Ming-Feng HouDirectorTWD 1.3m
  • Ms. Wen-Hung HsuDirectorTWD 84,000
  • Mr. Yi-Hui LinDirectorTWD 60,000
  • Mr. Ming-Shiang WuDirectorTWD 84,000
  • Mr. Rui-Wen WuDirectorTWD 84,000
  • Wen-Ta ChiuIndependent Director
  • Mr. Chien-Huang LinIndependent DirectorTWD 1.7m
  • Ms. Pau-Chu LoIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • PharmaEngine Inc has 16,000 employees.
  • The company is headquartered in Taipei City, Taiwan.
  • It has an IPO date of 2011-09-01.

Weaknesses

  • The company's website is listed as https://www.pharmaengine.com/tw/index.
  • The source description is marked as untrusted.
  • The company's product development details are not fully verified.

Opportunities

  • PharmaEngine is developing three new anti-cancer drugs under the brand ONIVYDE.
  • The firm distributes its products mainly to overseas markets.
  • The company operates in the Health Care sector within Biotechnology.

Threats

  • The source description is untrusted and may contain inaccurate information.
  • The company's product development status is not fully confirmed.
  • The firm's reliance on overseas markets could pose risks.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.